SCHEMBL6203623

SCHEMBL6203623

COc1cc2c(cc1OC)-c1[nH]c3ccc(O)cc3c1C2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 9/20 0.47
CHEK1 O14757 8/20 0.47
ROCK2 O75116 2/20 0.43
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
CASP6 P55212 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
RET P07949 1/20 0.40
CCNB2 O95067 3/20 0.40
CDK1 P06493 3/20 0.40
CCNB1 P14635 3/20 0.40
GSK3B P49841 3/20 0.40
CDK5 Q00535 3/20 0.40
CDK5R1 Q15078 3/20 0.40
CCNB3 Q8WWL7 3/20 0.40
FLT3 P36888 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7227282 0.99 WEE1 (0.46) WEE1CHEK1ROCK2MEN1POLB
SCHEMBL6203750 0.85 ALDH1A1 (0.50) ROCK2MEN1POLBGAAKMT2A
Hydrochloric Acid SCHEMBL7234662 0.84 ABCG2 (0.49) ROCK2MEN1POLBGAAKMT2A
SCHEMBL6200212 0.83 CA1 (0.52) MEN1KMT2ATDP1CCNB2CDK1
SCHEMBL6506227 0.82 WEE1 (0.48) WEE1CHEK1ROCK2MEN1POLB
SCHEMBL6499254 0.82 ROCK2 (0.48) WEE1CHEK1ROCK2CCNB2CDK1
SCHEMBL6202494 0.82 ALDH1A1 (0.51) WEE1CHEK1ROCK2CCNB2CDK1
Hydrochloric Acid SCHEMBL7226744 0.82 CA1 (0.51) MEN1KMT2ATDP1CCNB2CDK1
Hydrochloric Acid SCHEMBL7226290 0.81 ALDH1A1 (0.50) WEE1CHEK1ROCK2CCNB2CDK1
SCHEMBL6496944 0.79 WEE1 (0.46) WEE1CHEK1ROCK2MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1266887-B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-08-17 EP disclosed
US-6844445-B2 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2005-01-18 US disclosed
EP-1245565-B1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-09-24 EP disclosed
EP-1266887-A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-12-18 EP disclosed
US-20020173531-A1 Indenoindolone compounds LES LABORATOIRES SERVIER (FR) 2002-11-21 US disclosed
EP-1245565-A1 Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020173531-A1 Indenoindolone compounds MTNR1A, MTNR1B, CYP11B1 WEE1 3618/4885CHEK1 4552/4885ROCK2 2889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.